检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:陈丽贤[1] 邹红玲[1] 陈历排[1] 傅文红[1] 黄守松 赵营[1] 黄芊芊[1]
机构地区:[1]广州医科大学附属肿瘤医院妇科,广东广州510095
出 处:《热带医学杂志》2015年第6期770-772,共3页Journal of Tropical Medicine
基 金:广东省中医管理局基金(20121128)
摘 要:目的分析个体化手术治疗Ia-Ⅱb期宫颈癌患者生存状态,探讨影响预后的高危因素。方法对我院2004-2009年期间宫颈癌211例患者手术治疗后生存状态进行分析,累计生存曲线通过Kaplan-Meier法计算,以表示患者的预后情况。单因素分析采用Log-rank检验,多因素分析采用Cox回归分析,以探讨影响预后的因素。结果 211例宫颈癌患者的临床分期为Ia期23例,Ib1期73例,Ib2期77例,Ⅱa期为20例,Ⅱb为18例,5年生存率分别是100.00%、95.83%、83.02%、78.95%、61.11%。手术治疗Ⅰa-Ⅱb期宫颈癌患者的5年生存率为87.04%。单因素分析提示临床分期、宫颈肌层浸润程度、淋巴结转移情况与宫颈癌预后相关(P<0.05),多因素分析发现临床分期与宫颈癌预后有关,RR(95%CI)=2.27(1.66,3.11)。结论手术治疗Ia期-Ⅱb期宫颈癌患者的5年生存率为87.04%,临床分期的逐级变化与宫颈癌预后有关。Objective To study the survival situation after surgical operation of the cervical cancer patients from stage-Ia to stage-IIb and explore their high-risk factors of prognosis. Methods 211 surgery cervical cancer patients during 2004 to 2009 were included in this study. Kaplan-Meier method was used to obtain the survival rate; Log-rank test and Cox model multi-factor analysis were used to investigate the prognosis correlation factors. Results The 5-year survival rates of patients with cervical cancer at stages Ia(23 cases), Ib1(73 cases), Ib2(77 cases), Ⅱ a(20 cases) and Ⅱ b(18 cases) were 100.00%, 95.83%, 83.02%, 78.95% and 61.11%, respectively. The 5-year survival rate of the 211 patients was 87.04%. The single factor analysis showed that different clinical stages, cervical muscular infiltration and lymph node metastasis have relationship with cervical cancer prognosis(P〈0.05). However, multi-factor analysis showed that only pathological stage was related to the cancer prognosis, RR(95% CI) was 2.27(1.66, 3.11). Conclusions The 5-year survival rate of the 211 patients was 87.04%. Clinical stage has relationship with cervical cancer prognosis.
分 类 号:R373.33[医药卫生—病原生物学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:3.144.115.20